Aurinia Pharmaceuticals AUPH Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's tax on share settlement?
- Aurinia Pharmaceuticals (AUPH) reported tax on share settlement of $14.58M in Q1 2026.
- How has Aurinia Pharmaceuticals's tax on share settlement changed year-over-year?
- Aurinia Pharmaceuticals's tax on share settlement increased by 63.2% year-over-year, from $8.93M to $14.58M.
- What is the long-term trend for Aurinia Pharmaceuticals's tax on share settlement?
- Over 3 years (2022 to 2025), Aurinia Pharmaceuticals's tax on share settlement has grown at a 111.0% compound annual growth rate (CAGR), from $1.04M to $9.76M.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.